HoopsHype Fines rumors

April 19, 2014 Updates

This marks the second time in less than two months that the NBA's drug program has drawn unwanted attention, as U.S. Anti-Doping Agency CEO Travis Tygart told ESPN in early March that it was "not at all" difficult to beat. Buchanan, in an interview with USA TODAY Sports, discussed his polar-opposite tenor of the unsatisfactory reviews and defended the league's system. "If you measure (the program) by the list of substances that we banned, the number of times that we test (six annually), the percentage of a season that you miss if you're penalized under the program, the labs we use, the processes we use, all that stuff is as good or better than the programs in the other leagues, but we've kind of been given a bit of a hard time about that," Buchanan said by phone. "And then we have a positive (testing) situation, and a penalty, and the questions then go in another direction, which is, 'Gee, isn't this harsh?...We can't seem to catch a break." USA Today Sports

According to the Mayo Clinic's website, Tamoxifen blocks the effects of the estrogen hormone in the body and is commonly used to treat breast cancer in men and women. In the sports world, it's more commonly used to reduce the side effects of steroids. In June of 2012, free agent outfielder Marlon Byrd was suspended 50 games by Major League Baseball after testing positive for Tamoxifen. But Calathes, who is filing a grievance on the ruling, said in a statement to USA TODAY Sports that he didn't take the substance to gain any sort of edge. "I deeply regret my actions and apologize to my teammates and the organization for my poor judgment," Calathes said by phone. "Let me be clear: I never took any medication whatsoever for a performance-enhancing reason. I don't agree with this outcome, and I will come back a better player and person when I return." USA Today Sports

April 18, 2014 Updates
April 17, 2014 Updates
April 16, 2014 Updates
April 14, 2014 Updates
April 12, 2014 Updates
April 11, 2014 Updates
April 10, 2014 Updates
April 9, 2014 Updates

Bucks officials confirmed that fourth-year center Larry Sanders has started his five-game suspension for violating the league's drug policy. Sanders was not with the Bucks for their Wednesday game against Indiana and could not be at the arena, per NBA policy. Sanders was suspended for a third positive marijuana test. He was out due to surgery for right orbital fractures and it was uncertain when his suspension would begin. But this means the 6-foot-11 Sanders will not have to start next season with a suspension. Milwaukee Journal-Sentinel

Any rumor missing? E-mail us at   hoopshype@hoopshype.com.